Comparing 3 Schedules of Alimta Plus Gemzar
The purpose of the study is to measure tumor response rates for three schedules of Alimta(LY231514) in combination with gemcitabine in patients with locally advanced or metastatic non small cell lung cancer who have received no prior chemotherapy regimen.
Carcinoma, Non-Small-Cell Lung|Lung Neoplasms|Neoplasms
DRUG: Pemetrexed (Alimta) in combination with gemcitabine (Gemzar)
The purpose of the study is to measure tumor response rates for three schedules of Alimta(LY231514) in combination with gemcitabine in patients with locally advanced or metastatic non small cell lung cancer who have received no prior chemotherapy regimen.